Treatment of VTE

Treatment of VTE

0% Complete

Course Overview

This CME activity provides a practical, evidence-based review of the treatment of venous thromboembolism (VTE), including acute pulmonary embolism (PE) and deep vein thrombosis (DVT). The presentation examines how risk stratification guides treatment decisions, including the selection of patients who may benefit from advanced interventions such as systemic thrombolysis, catheter-directed therapy, or mechanical thrombectomy. It also addresses management considerations for isolated subsegmental PE and isolated distal DVT, including when anticoagulation or clinical surveillance may be appropriate.

Course Content

Credits

1.00
AMA PRA Category 1™ Credits

* AMA PRA Category 1™ credits are used by physicians and other groups like PAs and certain nurses. Category 1 credits are accepted by the ACCME, ARDMS, CCI, and Sonography Canada.

Course Details

Duration
1.00 hour
Released
Aug 31, 2026
Last Review
Aug 31, 2026
Expires
Aug 30, 2029

Objectives

At the conclusion of this activity, participants will be able to:

  1. Identify appropriate patients with acute pulmonary embolism (PE) who may benefit from interventional therapies.

  2. Determine when anticoagulation or clinical surveillance is appropriate for patients with isolated subsegmental PE and isolated distal DVT.

  3. Select an appropriate initial anticoagulant regimen for patients with acute DVT and PE based on clinical risk and patient factors.

  4. Evaluate the risks and benefits of extended anticoagulation following completion of initial treatment for DVT or PE.

  5. Apply current evidence and guideline recommendations to individualized VTE treatment decisions, including balancing the risks of recurrent VTE against major bleeding.

Target Audience

This CME activity is intended for physicians and other healthcare professionals involved in the evaluation and management of patients with venous thromboembolism (VTE), including acute pulmonary embolism (PE) and deep vein thrombosis (DVT).

It may be particularly relevant to:

  • Primary care physicians

  • Emergency medicine physicians

  • Hospitalists and inpatient physicians

  • Internal medicine physicians

  • Pulmonologists

  • Cardiologists

  • Hematologists

  • Vascular medicine specialists

  • Advanced practice clinicians involved in VTE management

  • Other healthcare professionals who participate in anticoagulation and thrombosis care

Faculty & Disclosure

Faculty

Financial Disclosures

None of the speakers, planners, or moderators for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing products used by or on patients.

This activity was developed without any financial support, influence, or involvement from any ineligible companies.

Mitigation of Relevant Financial Relationships

All of the relevant financial relationships listed for these individuals have been mitigated.  Remaining persons in control of content have no relevant financial relationships.

Accreditation

The Clark County Medical Society is accredited by the Utah Medical Association (UMA) to provide continuing medical education for physicians.

The Clark County Medical Society designates this live educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.